• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾病综合征中的低密度脂蛋白代谢

Low-density lipoprotein metabolism in the nephrotic syndrome.

作者信息

Warwick G L, Caslake M J, Boulton-Jones J M, Dagen M, Packard C J, Shepherd J

机构信息

Department of Pathological Biochemistry, Glasgow Royal Infirmary, United Kingdom.

出版信息

Metabolism. 1990 Feb;39(2):187-92. doi: 10.1016/0026-0495(90)90074-m.

DOI:10.1016/0026-0495(90)90074-m
PMID:2299990
Abstract

Hyperlipidemia is a consistent feature of the nephrotic syndrome. In this study, low-density lipoprotein (LDL) metabolism has been investigated in nine patients with nephrotic syndrome and varying degrees of proteinuria. In subjects with moderate proteinuria (less than 10 g/d), total plasma cholesterol values were elevated to approximately 160% of normal due mainly to an increase in circulating LDL cholesterol. Metabolic studies showed that a defect in LDL clearance via the receptor pathway was responsible for its accumulation. The total amount of LDL apolipoprotein catabolized by this mechanism was only 55% of the value seen in controls; 60% more LDL was channelled into alternative, receptor-independent, catabolic pathways. Heavier proteinuria was associated with substantial increases in plasma triglyceride and very-low-density lipoprotein (VLDL) levels. The defect in LDL catabolism was aggravated by oversynthesis of the lipoprotein, which expanded the plasma LDL pool to 250% of normal. These observations indicate that the hyperlipidemia of the nephrotic syndrome is multifactorial in origin. The altered catabolism of LDL may be important in predisposing these subjects to premature atherosclerosis.

摘要

高脂血症是肾病综合征的一个持续特征。在本研究中,对9例患有肾病综合征且蛋白尿程度不同的患者进行了低密度脂蛋白(LDL)代谢研究。在中度蛋白尿(低于10 g/d)的受试者中,血浆总胆固醇值升高至正常水平的约160%,主要是由于循环中的LDL胆固醇增加。代谢研究表明,通过受体途径清除LDL存在缺陷是其蓄积的原因。通过该机制分解代谢的LDL载脂蛋白总量仅为对照组的55%;60%以上的LDL进入了替代性的、不依赖受体的分解代谢途径。蛋白尿较重与血浆甘油三酯和极低密度脂蛋白(VLDL)水平大幅升高有关。脂蛋白过度合成加剧了LDL分解代谢的缺陷,使血浆LDL池扩大至正常水平的250%。这些观察结果表明,肾病综合征的高脂血症起源是多因素的。LDL分解代谢改变可能在使这些受试者易患早发性动脉粥样硬化方面起重要作用。

相似文献

1
Low-density lipoprotein metabolism in the nephrotic syndrome.肾病综合征中的低密度脂蛋白代谢
Metabolism. 1990 Feb;39(2):187-92. doi: 10.1016/0026-0495(90)90074-m.
2
Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.肾病综合征中低密度脂蛋白代谢及其与血浆脂蛋白(a)的关联。
Eur J Clin Invest. 1997 Feb;27(2):169-77. doi: 10.1046/j.1365-2362.1997.930641.x.
3
Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism.洛伐他汀治疗肾病性高脂血症:对脂蛋白代谢的影响。
Kidney Int. 1988 Jun;33(6):1160-8. doi: 10.1038/ki.1988.125.
4
Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.肾病患者极低密度脂蛋白(VLDL)增加是由于分解代谢降低,而低密度脂蛋白(LDL)增加则是由于合成增加。
Kidney Int. 1998 Apr;53(4):994-1001. doi: 10.1111/j.1523-1755.1998.00831.x.
5
Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria.肾病范围蛋白尿患者中含载脂蛋白B脂蛋白的代谢
Kidney Int. 1991 Jul;40(1):129-38. doi: 10.1038/ki.1991.190.
6
Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.低白蛋白血症会增加正常胆固醇水平受试者低密度脂蛋白中的溶血磷脂酰胆碱。
Kidney Int. 1999 Mar;55(3):1005-10. doi: 10.1046/j.1523-1755.1999.0550031005.x.
7
Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.酰基辅酶A:胆固醇酰基转移酶抑制可改善肾病综合征中的蛋白尿、高脂血症、卵磷脂胆固醇酰基转移酶、SRB-1及低密度脂蛋白受体缺陷。
Circulation. 2004 Jul 27;110(4):419-25. doi: 10.1161/01.CIR.0000136023.70841.0F. Epub 2004 Jul 19.
8
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.肾病综合征中的脂质代谢紊乱:机制与后果
Kidney Int. 2016 Jul;90(1):41-52. doi: 10.1016/j.kint.2016.02.026. Epub 2016 Apr 26.
9
Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.人系膜细胞和肝细胞对肾病患者中密度脂蛋白的优先摄取。
J Am Soc Nephrol. 1994 Oct;5(4):1081-90. doi: 10.1681/ASN.V541081.
10
Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.患有肾病范围蛋白尿的患者存在载脂蛋白C和E缺乏的极低密度脂蛋白1。
Kidney Int. 2000 Sep;58(3):1238-46. doi: 10.1046/j.1523-1755.2000.00278.x.

引用本文的文献

1
Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation.慢性肾脏病及肾移植中的脂蛋白异常
Life (Basel). 2021 Apr 5;11(4):315. doi: 10.3390/life11040315.
2
Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk.载脂蛋白组成特征与白蛋白尿相互作用调节心血管疾病风险。
Int J Mol Sci. 2019 Feb 23;20(4):977. doi: 10.3390/ijms20040977.
3
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.肾病综合征中的血脂异常:机制与治疗
Nat Rev Nephrol. 2018 Jan;14(1):57-70. doi: 10.1038/nrneph.2017.155. Epub 2017 Nov 27.
4
Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy.氯沙坦和螺内酯对糖尿病肾病中富含甘油三酯脂蛋白的影响。
J Investig Med. 2016 Aug;64(6):1102-8. doi: 10.1136/jim-2016-000102. Epub 2016 Jul 7.
5
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.前蛋白转化酶枯草溶菌素/克新9型在肾病综合征相关高胆固醇血症中的作用
Circulation. 2016 Jul 5;134(1):61-72. doi: 10.1161/CIRCULATIONAHA.115.020912.
6
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.肾病综合征中的脂质代谢紊乱:机制与后果
Kidney Int. 2016 Jul;90(1):41-52. doi: 10.1016/j.kint.2016.02.026. Epub 2016 Apr 26.
7
Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.慢性肾脏病和终末期肾病患儿血脂异常的病因及管理
Pediatr Nephrol. 2015 Dec;30(12):2073-84. doi: 10.1007/s00467-015-3075-9. Epub 2015 Mar 24.
8
Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.在预防肾脏和血管终末期疾病(PREVEND)研究参与者中,载脂蛋白B可减轻与蛋白尿相关的心血管疾病。
J Am Soc Nephrol. 2014 Dec;25(12):2906-15. doi: 10.1681/ASN.2013121256. Epub 2014 May 22.
9
Monascus purpureus Went rice in nephrotic hyperlipidemia.
Indian J Nephrol. 2008 Apr;18(2):58-63. doi: 10.4103/0971-4065.42334.
10
Efficacy and safety of Monascus purpureus Went rice in subjects with secondary hyperlipidemia.红曲米对继发性高脂血症患者的疗效及安全性
Clin Exp Nephrol. 2008 Jun;12(3):189-94. doi: 10.1007/s10157-008-0033-x. Epub 2008 Mar 26.